K. Ienaga et al., CROSSLINE-LIKE STRUCTURE ACCUMULATES AS FLUORESCENT ADVANCED GLYCATION END-PRODUCTS IN RENAL TISSUES OF RATS WITH DIABETIC NEPHROPATHY, Proceedings of the Japan Academy. Series B Physical and biological sciences, 72(4), 1996, pp. 79-84
Although formation of characteristic fluorescence (Ex(max)/Em(max):370
/440 nm) in renal tissues has been known to be enhanced in diabetic mo
del rats and the natural fluorophores have been thought as advanced gl
ycation end products (AGEs), these structures remain unclear to this e
late. Since we had already isolated crossline derivatives as the main
fluorescent AGE-products formed in a sugar-amine-model system in vitro
, we tried to determine whether crossline-like structure can be found
in renal tissues of rats with diabetic nephropathy. Specific polyclona
l antiserum against crossline-structure and its affinity chromatograph
y-purified antibody were prepared. The purified antibody did not recog
nize native rat serum albumin (RSA), but it recognized RSA modified by
prolonged incubation with high concentration of glucose (AGE-RSA) as
well as the crossline-hapten. The immunoreactivity of AGE-RSA was comp
letely blocked by co-incubation with crossline-derivative. These resul
ts confirm immunochemically that in vitro-prepared AGE-proteins contai
n crossline-like structure. Similarly, crossline-like structure in AGE
-proteins in vivo was examined immunohistochemically. In streptozotoci
n-induced diabetic rats, both crossline-like immunoreactivity and fluo
rescence (Ex/Em:370/440 nm) of renal tissues increased, and the levels
rose further with progression of diabetic nephropathy. Crossline accu
mulation was observed in specific renal tissues such as glomeruli (bas
ement membrane and mesangium), tubules, and Bowman's capsules. Althoug
h the contribution of crossline-like substance(s) to total fluoroescen
ce in diabetic renal tissues has not as yet been quantitatively determ
ined, our results provide evidence that crossline accumulation occurs
in renal tissues of rats in association with the initiation and/or pro
gression of diabetic nephropathy.